Product NDC: | 49884-459 |
Proprietary Name: | Fentanyl Citrate |
Non Proprietary Name: | Fentanyl Citrate |
Active Ingredient(s): | 200 ug/1 & nbsp; Fentanyl Citrate |
Administration Route(s): | ORAL; TRANSMUCOSAL |
Dosage Form(s): | LOZENGE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-459 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077312 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111017 |
Package NDC: | 49884-459-55 |
Package Description: | 30 BLISTER PACK in 1 CARTON (49884-459-55) > 1 LOZENGE in 1 BLISTER PACK (49884-459-52) |
NDC Code | 49884-459-55 |
Proprietary Name | Fentanyl Citrate |
Package Description | 30 BLISTER PACK in 1 CARTON (49884-459-55) > 1 LOZENGE in 1 BLISTER PACK (49884-459-52) |
Product NDC | 49884-459 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fentanyl Citrate |
Dosage Form Name | LOZENGE |
Route Name | ORAL; TRANSMUCOSAL |
Start Marketing Date | 20111017 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 200 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |